Literature DB >> 12559076

Prognostic significance of caspase-3 expression in primary resected esophageal squamous cell carcinoma.

Jiun-Yi Hsia1, Chih-Yi Chen, Jung-Ta Chen, Chung-Ping Hsu, Sen-Ei Shai, Shyh-Sheng Yang, Cheng-Yen Chuang, Pei-Yen Wang, Jen Miaw.   

Abstract

AIMS: The present study retrospectively examines the expression of caspase-3 in primary resected esophageal squamous cell carcinoma (ESCC) and the correlation between the outcome of patients and the expression of proteins.
METHODS: Immunohistochemistry and Western blot analyses were used to analyse the expression of caspase-3 in 40 archival specimens of patients with primary resected ESCC.
RESULTS: According to our cut-off point of the staining for caspase-3, 24 (60%) cases were positive and 16 (40%) negative. Caspase-3 expression correlated with a significant favorable prognosis in primary resected ESCC (P=0.02). A multivariate analysis of clinical and biological factors indicated that stage, tumor differentiation, and caspase-3 expression were independent prognostic factors.
CONCLUSIONS: Caspase-3 expression might be a good and new prognostic indicator for primary resected ESCC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12559076     DOI: 10.1053/ejso.2002.1338

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  13 in total

1.  Genomic imbalances in esophageal squamous cell carcinoma identified by molecular cytogenetic techniques.

Authors:  Marilanda Ferreira Bellini; Ana Elizabete Silva; Marileila Varella-Garcia
Journal:  Genet Mol Biol       Date:  2010-06-01       Impact factor: 1.771

2.  Immunohistochemical analysis of pro- and active-caspase 3 in laryngeal squamous cell carcinoma.

Authors:  Andrej Cör; Joze Pizem; Nina Gale
Journal:  Virchows Arch       Date:  2004-03-25       Impact factor: 4.064

3.  Differences of onset age and survival rates in esophageal squamous cell carcinoma cases with and without family history of upper gastrointestinal cancer from a high-incidence area in North China.

Authors:  Denggui Wen; Shijie Wang; Liwei Zhang; Jianhui Zhang; Lizhen Wei; Xiuqing Zhao
Journal:  Fam Cancer       Date:  2006-05-25       Impact factor: 2.375

4.  Caspase-3 expression in metastatic lymph nodes of esophageal squamous cell carcinoma is prognostic of survival.

Authors:  Xiu-Shen Wang; Kong-Jia Luo; Amos Ela Bella; Shan-Shan Bu; Jing Wen; Shui-Shen Zhang; Yi Hu
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

5.  Expression of caspase-3 and c-myc in non-small cell lung cancer.

Authors:  Jin young Yoo; Chi Hong Kim; So Hyang Song; Byoung Yong Shim; Youn Ju Jeong; Meyung Im Ahn; Suji Kim; Deog Gon Cho; Min Seop Jo; Kyu Do Cho; Hong Joo Cho; Seok Jin Kang; Hoon Kyo Kim
Journal:  Cancer Res Treat       Date:  2004-10-31       Impact factor: 4.679

Review 6.  Prognostic value of Caspase-3 expression in cancers of digestive tract: a meta-analysis and systematic review.

Authors:  Hao Chen; Xia Yang; Zhenbo Feng; Ruixue Tang; Fanghui Ren; Kanglai Wei; Gang Chen
Journal:  Int J Clin Exp Med       Date:  2015-07-15

7.  Effect of small interfering RNA transfection on FAK and DLC1 mRNA expression in OVCAR-3.

Authors:  Huirong Shi; Huina Liu; Guoqiang Zhao
Journal:  Mol Biol Rep       Date:  2012-07-04       Impact factor: 2.316

8.  Effect of NF-kappaB, survivin, Bcl-2 and Caspase3 on apoptosis of gastric cancer cells induced by tumor necrosis factor related apoptosis inducing ligand.

Authors:  Liu-Qin Yang; Dian-Chun Fang; Rong-Quan Wang; Shi-Ming Yang
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

9.  Antitumor activity of folate-targeted, paclitaxel-loaded polymeric micelles on a human esophageal EC9706 cancer cell line.

Authors:  Wenbin Wu; Yonghui Zheng; Rui Wang; Weili Huang; Lei Liu; Xiuli Hu; Shi Liu; Jun Yue; Ti Tong; Xiabin Jing
Journal:  Int J Nanomedicine       Date:  2012-07-06

Review 10.  Does Notch play a tumor suppressor role across diverse squamous cell carcinomas?

Authors:  Min Zhang; Sangita Biswas; Xin Qin; Wenrong Gong; Wenbing Deng; Hongjun Yu
Journal:  Cancer Med       Date:  2016-05-26       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.